TG Therapeutics, Inc. (TGTX)
NASDAQ·Healthcare·Biotechnology
$34.77
-1.72%
Mkt Cap $6.12B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $191.79M | $192.57M | +0.41% | $0.35 | $0.14 | -60.00% | — | — |
| Q4 2025 Nov 3, 2025 | $193.80M | $161.71M | -16.56% | $0.24 | $2.43 | +912.50% | — | — |
| Q3 2025 Aug 4, 2025 | $146.27M | $141.15M | -3.50% | $0.32 | $0.17 | -46.88% | — | — |
| Q2 2025 May 5, 2025 | $134.20M | $120.86M | -9.94% | $0.18 | $0.03 | -83.33% | — | — |
| Q1 2025 Mar 3, 2025 | $108.80M | $108.19M | -0.57% | $0.08 | $0.15 | +87.50% | — | — |
| Q4 2024 Nov 4, 2024 | $98.79M | $83.88M | -15.09% | $0.03 | $0.02 | -33.33% | — | — |
| Q3 2024 Aug 6, 2024 | $65.89M | $73.47M | +11.50% | -$0.05 | $0.04 | +180.00% | — | — |
| Q2 2024 May 1, 2024 | $54.61M | $63.47M | +16.23% | -$0.04 | -$0.07 | -96.02% | — | — |
| Q1 2024 Feb 28, 2024 | $40.06M | $43.97M | +9.76% | -$0.12 | -$0.09 | +25.00% | — | — |
| Q4 2023 Nov 1, 2023 | $38.68M | $165.81M | +328.68% | $0.12 | $0.73 | +508.33% | — | — |
| Q3 2023 Aug 1, 2023 | $47.14M | $16.07M | -65.90% | -$0.26 | -$0.34 | -30.77% | — | — |
| Q2 2023 May 1, 2023 | $14.43M | $7.80M | -45.93% | -$0.36 | -$0.28 | +22.22% | — | — |
| Q1 2023 Feb 28, 2023 | $1.60M | $80.00K | -95.01% | -$0.26 | -$0.39 | -50.00% | — | — |
| Q4 2022 Nov 10, 2022 | $1.46M | $94.00K | -93.54% | -$0.33 | -$0.26 | +21.21% | — | — |
| Q3 2022 Aug 8, 2022 | $175.43K | $594.00K | +238.60% | -$0.49 | -$0.30 | +38.78% | — | — |
| Q2 2022 May 10, 2022 | $2.08M | $2.02M | -3.11% | -$0.55 | -$0.51 | +7.27% | — | — |
| Q1 2022 Mar 1, 2022 | $2.24M | $2.32M | +3.62% | -$0.62 | -$0.70 | -12.90% | — | — |
| Q4 2021 Nov 4, 2021 | $2.97M | $2.03M | -31.65% | -$0.56 | -$0.65 | -16.07% | — | — |
| Q3 2021 Aug 2, 2021 | $3.49M | $1.54M | -55.73% | -$0.48 | -$0.59 | -22.92% | — | — |
| Q2 2021 May 10, 2021 | $770.00K | $793.00K | +2.99% | -$0.52 | -$0.69 | -32.69% | — | — |